$SFIX

Bacos Anthony sold $310K of SFIX

Bacos Anthony (Chief Prod/Technology Officer) sold 70,011 shares of Stitch Fix, Inc. (SFIX) at an average of $4.42 ($4.42–$4.42, $0.31M total) across 2 trades on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bacos Anthony
Published Jul 1, 2026, 10:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$SFIX
Neutral
medium confidence
Mentioned
$SFIX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SFIXNeutralLow
01

Why it matters

The newest fact is the officer’s disclosed open-market sale details (shares, price range, total value) and confirmation of a pre-arranged 10b5-1 plan.

02

Market read

This provides a fresh, auditable insider-sale datapoint for SFIX, but it does not change company fundamentals.

03

What to watch

Traders may still watch for follow-on insider activity (additional Form 4s) or whether the sale coincides with broader stock weakness, but this article alone doesn’t provide that context.

Relevance 3/10Novelty 3/10Timing: SEC Form 4 filed 2026-07-01 for a 2026-06-29 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Stitch Fix, Inc. (SFIX).

Company-level read

Ticker impact

$SFIXNeutralMedium confidence
Context

Stitch Fix officer Bacos Anthony sold 70,011 shares in open-market transactions on 2026-06-29 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

Form 4 provides a concrete datapoint (sale size, weighted average price, and 10b5-1 pre-arrangement), yet the filing does not introduce new company-specific operating or financial information.

Market effects

Minimal; this is a single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity rather than negative expectations.

Key entities

  • Stitch Fix, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Bacos Anthony

    Chief Product/Technology Officer who sold shares.

  • 10b5-1 plan

    Pre-arranged plan cited as Yes in the filing.

Related articles

$SFIXMedAI 8/10

Why Stitch Fix Stock Surged Today

Stitch Fix shares rose 15.69% on Thursday after the company reported fiscal 2026 Q3 results that beat investor expectations. Revenue increased 4.7% to $340 million; net revenue per active client rose 6.6% to $578. Net loss narrowed to $1.5 million, free cash flow was $6.5 million, and adjusted EBITDA rose 20% to $13.2 million. Stitch Fix raised full-year guidance to about $1.35 billion revenue and $49–$52 million adjusted EBITDA, with positive free cash flow.

$ORCLMedAI 8/10

Futures Rise, Oil Drops As US Ends Iran Strikes

US equity futures rose as tech and small caps gained after US Central Command said strikes against Iran were complete, easing concerns about further escalation and the Strait of Hormuz reopening. S&P futures rose 0.7% and Nasdaq 100 1.1%; bond yields fell 1–3bp. Brent slipped ~1% below $92; WTI fell to $88.87. Oracle shares fell ~8% after higher-than-estimated capex; Navan jumped 19% after raising revenue outlook.